INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Four Reasons You Should Choose Lyophilization for Your Next Project

  Lyophilization ensures product stability, extends shelf life, supports sensitive formulations, and simplifies storage and transport, making it a critical choice for modern drug development projects.

• Moving Batch Release Into The Fast Lane

  Complex supply chains and fragmented systems slow batch release, delaying patient access and revenue goals. Learn how automation and centralized data improve compliance and accelerate delivery.

• Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

  Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

• Removing The Headache: Outsourced Stability Storage And Testing Solutions

  Should you manage certain operations internally or partner with a trusted external provider? Watch experts discuss the benefits of outsourcing stability, storage, and testing.

• Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals

  10/24/2024

  Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

• Top Safety Considerations In Biopharmaceutical Manufacturing

  4/16/2025

  Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

• The Way Forward: Supply Chain Solutions

  10/24/2024

  Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.

• Shedding Light On Photo-Stability Forced Degradation

  11/26/2024

  Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.

• Risk Mitigation For Late-Stage Clinical Assets

  6/11/2025

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.